Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             112 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma Wang, Pengyu

9 p. 1396-1408.e8
artikel
2 A chemogenetic platform for controlling plasma membrane signaling and synthetic signal oscillation Suzuki, Sachio

9 p. 1446-1464.e10
artikel
3 Activation of Caspase-6 Is Promoted by a Mutant Huntingtin Fragment and Blocked by an Allosteric Inhibitor Compound Ehrnhoefer, Dagmar E.
2019
9 p. 1295-1305.e6
artikel
4 A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection Vijayan, Kamalakannan

9 p. 1419-1433.e5
artikel
5 A MALDI-TOF Approach to Ubiquitin Ligase Activity van Tol, Bianca D.M.
2018
9 p. 1053-1055
artikel
6 Anaerobic purinolytic enzymes enable dietary purine clearance by engineered gut bacteria Tong, Yang

9 p. 1104-1114.e7
artikel
7 Analyzing Resistance to Design Selective Chemical Inhibitors for AAA Proteins Pisa, Rudolf
2019
9 p. 1263-1273.e5
artikel
8 A New Staple: Peptide-Targeted Covalent Inhibitors Leverson, Joel D.
2016
9 p. 1043-1044
2 p.
artikel
9 An Isoform-Selective Modulator of Cryptochrome 1 Regulates Circadian Rhythms in Mammals Miller, Simon

9 p. 1192-1198.e5
artikel
10 A Plasma Protein Network Regulates PM20D1 and N-Acyl Amino Acid Bioactivity Kim, Joon T.

9 p. 1130-1139.e4
artikel
11 Approaches and Guidelines for the Identification of Novel Substrates of Protein Lysine Methyltransferases Kudithipudi, Srikanth
2016
9 p. 1049-1055
7 p.
artikel
12 Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs Velagapudi, Sai Pradeep
2018
9 p. 1086-1094.e7
artikel
13 A Quantitative Chemoproteomic Platform to Monitor Selenocysteine Reactivity within a Complex Proteome Bak, Daniel W.
2018
9 p. 1157-1167.e4
artikel
14 A Rapid and Precise Mutation-Activated Fluorescence Reporter for Analyzing Acute Mutagenesis Frequency Birnbaum, Michael D.

9 p. 1220
artikel
15 Biasing Opioid Receptors and Cholesterol as a Player in Developmental Biology Kostic, Milka
2016
9 p. 1039-1040
2 p.
artikel
16 Bioorthogonal dissection of the replicase assembly of hepatitis C virus Zhang, Yang

9 p. 1366-1378.e4
artikel
17 Boosting glycolysis to combat fragile bone in type 1 diabetes Jin, Zixue

9 p. 1002-1003
artikel
18 Break Away: FKBP12 sequestration as a target for increasing BMP activity Taubert, Martha C.

9 p. 1253-1255
artikel
19 Bypassing Kinase Signaling in Mammalian Cells Neumann, Heinz
2018
9 p. 1051-1053
artikel
20 Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria Emslander, Quirin

9 p. 1434-1445.e7
artikel
21 Challenges and opportunities in targeting metabolism Birsoy, Kivanç

9 p. 999-1001
artikel
22 Chemical Biology as a Driver of Innovation in Cancer Research and Drug Discovery Kostic, Milka
2017
9 p. 1057-
1 p.
artikel
23 Chemical Inhibition of Protein Methyltransferases Schapira, Matthieu
2016
9 p. 1067-1076
10 p.
artikel
24 Chemical Targeting of a G-Quadruplex RNA in the Ebola Virus L Gene Wang, Shao-Ru
2016
9 p. 1113-1122
10 p.
artikel
25 Combined Proteomic and In Silico Target Identification Reveal a Role for 5-Lipoxygenase in Developmental Signaling Pathways Brand, Silke
2018
9 p. 1095-1106.e23
artikel
26 Context-dependent regulation of ferroptosis sensitivity Magtanong, Leslie

9 p. 1409-1418.e6
artikel
27 Cut it out! A CRISPR-Cas9 screen identifies host regulators of the Plasmodium liver stage Chirgwin, Michael E.

9 p. 1365-1367
artikel
28 Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane Disruption Lawrence, Nicole
2018
9 p. 1140-1150.e5
artikel
29 Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor Skwarska, Anna

9 p. 1258-1270.e13
artikel
30 Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis Zupancic, Jennifer M.

9 p. 1379-1388.e7
artikel
31 Discovery of a Novel DNA Gyrase-Targeting Antibiotic through the Chemical Perturbation of Streptomyces venezuelae Sporulation McAuley, Scott
2019
9 p. 1274-1282.e4
artikel
32 Discovery of compounds that reactivate p53 mutants in vitro and in vivo Durairaj, Geetha

9 p. 1381-1395.e13
artikel
33 Discovery of Druggable Host Factors Critical to Plasmodium Liver-Stage Infection Raphemot, Rene
2019
9 p. 1253-1262.e5
artikel
34 Discovery of Small-Molecule Selective mTORC1 Inhibitors via Direct Inhibition of Glucose Transporters Kang, Seong A.
2019
9 p. 1203-1213.e13
artikel
35 Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets Sumi, Natalia J.
2019
9 p. 1240-1252.e11
artikel
36 Drug Discovery and Chemical Biology of Cancer Epigenetics Ribich, Scott
2017
9 p. 1120-1147
28 p.
artikel
37 Emerging Opportunities for Target Discovery in Rare Cancers Sharifnia, Tanaz
2017
9 p. 1075-1091
17 p.
artikel
38 Engineering Forward Genetics into Cultured Cancer Cells for Chemical Target Identification Povedano, Juan Manuel
2019
9 p. 1315-1321.e3
artikel
39 Ferroptosis execution: Is it all about ACSL4? Lee, Hyemin

9 p. 1363-1365
artikel
40 For Wnt Signaling, Fucosylation of LRP6 Is a Bitter Pill Shami Shah, Adnan

9 p. 1114-1116
artikel
41 Fragment-linking peptide design yields a high-affinity ligand for microtubule-based transport Cross, Jessica A.

9 p. 1347-1355.e5
artikel
42 From Catalytic Antibodies to Antibody-Drug Conjugates Dimitrov, Dimiter S.
2019
9 p. 1200-1201
artikel
43 Genetic activation of glycolysis in osteoblasts preserves bone mass in type I diabetes Ji, Xing

9 p. 1053-1063.e5
artikel
44 Genetically Encoded Protein Phosphorylation in Mammalian Cells Beránek, Václav
2018
9 p. 1067-1074.e5
artikel
45 Glutamine availability unleashes dendritic cells’ anti-tumor power Corrado, Mauro

9 p. 1012-1014
artikel
46 How Sweet It Is: Small-Molecule Inhibitors of mTORC1 Glucose Sensing Zhang, Junbing
2019
9 p. 1195-1196
artikel
47 Hydroxyproline metabolism enhances IFN-γ-induced PD-L1 expression and inhibits autophagic flux Spangenberg, Stephan H.

9 p. 1115-1134.e10
artikel
48 Hypoxia-activated KDAC inhibitor: Taking a breath from untargeted therapy Staudt, Maximilian

9 p. 1255-1257
artikel
49 Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis Hendricks, Joseph M.

9 p. 1090-1103.e7
artikel
50 Inducible Degradation of Target Proteins through a Tractable Affinity-Directed Protein Missile System Simpson, Luke M.

9 p. 1164-1180.e5
artikel
51 Inhibition of Bacterial Gene Transcription with an RpoN-Based Stapled Peptide Payne, Sterling R.
2018
9 p. 1059-1066.e4
artikel
52 Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth Reckzeh, Elena S.
2019
9 p. 1214-1228.e25
artikel
53 Inhibition of Staphylococcus aureus biofilm-forming functional amyloid by molecular tweezers Malishev, Ravit

9 p. 1310-1320.e5
artikel
54 In Situ Fucosylation of the Wnt Co-receptor LRP6 Increases Its Endocytosis and Reduces Wnt/β-Catenin Signaling Hong, Senlian

9 p. 1140-1150.e4
artikel
55 Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis Yu, Shan

9 p. 1169-1182.e8
artikel
56 Integration of metabolism and regulation reveals rapid adaptability to growth on non-native substrates Trivedi, Vikas D.

9 p. 1135-1143.e5
artikel
57 In This Issue 2016
9 p. v-vii
nvt p.
artikel
58 In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system Chu, Lianhe

9 p. 1368-1380.e5
artikel
59 It Takes a Megalopolis to Relaunch a Journal: A Story of Gratitude Kostic, Milka
2016
9 p. 1037-1038
2 p.
artikel
60 Joining Forces: The Chemical Biology–Medicinal Chemistry Continuum Plowright, Alleyn T.
2017
9 p. 1058-1065
8 p.
artikel
61 Lipase Processing of Complex Lipid Antigens Sander, Peter
2016
9 p. 1044-1046
3 p.
artikel
62 Lysosomal Lipases PLRP2 and LPLA2 Process Mycobacterial Multi-acylated Lipids and Generate T Cell Stimulatory Antigens Gilleron, Martine
2016
9 p. 1147-1156
10 p.
artikel
63 Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy Hazama, Daisuke

9 p. 1181-1191.e7
artikel
64 Mechanistic MALDI-TOF Cell-Based Assay for the Discovery of Potent and Specific Fatty Acid Synthase Inhibitors Weigt, David
2019
9 p. 1322-1331.e4
artikel
65 Metabolic and chemical architecture of the mammalian circadian clock Laothamatas, Isara

9 p. 1033-1052
artikel
66 Metabolic modulation of mitochondrial mass during CD4+ T cell activation Kurmi, Kiran

9 p. 1064-1075.e8
artikel
67 Molecular basis of C-S bond cleavage in the glycyl radical enzyme isethionate sulfite-lyase Dawson, Christopher D.

9 p. 1333-1346.e7
artikel
68 Networking in Circulation: Lipoproteins, PM20D1, and N-acyl Amino Acid Bioactivity Saghatelian, Alan

9 p. 1112-1113
artikel
69 NREP contributes to development of NAFLD by regulating one-carbon metabolism in primary human hepatocytes De Jesus, Dario F.

9 p. 1144-1155.e4
artikel
70 N-Thio-β-lactams targeting L,D-transpeptidase-2, with activity against drug-resistant strains of Mycobacterium tuberculosis Martelli, Giulia

9 p. 1321-1332.e5
artikel
71 Parallel Glyco-SPOT Synthesis of Glycopeptide Libraries Mehta, Akul Y.

9 p. 1207-1219.e9
artikel
72 Phenotypic screen identifies calcineurin-sparing FK506 analogs as BMP potentiators for treatment of acute kidney injury Larraufie, Marie-Hélène

9 p. 1271-1282.e12
artikel
73 6-Phosphogluconate Dehydrogenase Links Cytosolic Carbohydrate Metabolism to Protein Secretion via Modulation of Glutathione Levels Li, Haoxin
2019
9 p. 1306-1314.e5
artikel
74 Profiling Substrate Promiscuity of Wild-Type Sugar Kinases for Multi-fluorinated Monosaccharides Keenan, Tessa

9 p. 1199-1206.e5
artikel
75 Protein acylation by saturated very long chain fatty acids and endocytosis are involved in necroptosis Pradhan, Apoorva J.

9 p. 1298-1309.e7
artikel
76 Regulation of Autophagic Flux by the 20S Proteasome Njomen, Evert
2019
9 p. 1283-1294.e5
artikel
77 Regulation of the endocytosis and prion-chaperoning machineries by yeast E3 ubiquitin ligase Rsp5 as revealed by orthogonal ubiquitin transfer Wang, Yiyang

9 p. 1283-1297.e8
artikel
78 Remembering Professor Amy Christine Anderson Schiffer, Celia
2016
9 p. 1041-1042
2 p.
artikel
79 Repurposing SGLT2 inhibitors for autoimmune diseases? YES, WE MAY! Certo, Michelangelo

9 p. 1009-1011
artikel
80 Resistance to Enediyne Antitumor Antibiotics by Sequestration Chang, Chin-Yuan
2018
9 p. 1075-1085.e4
artikel
81 Sabotaging the breaks: FSEN1 expands the toolbox of FSP1 inhibitors Xavier da Silva, Thamara Nishida

9 p. 1006-1008
artikel
82 Screening in serum-derived medium reveals differential response to compounds targeting metabolism Abbott, Keene L.

9 p. 1156-1168.e7
artikel
83 Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors Huhn, Annissa J.
2016
9 p. 1123-1134
12 p.
artikel
84 Sequencing Mirror-Image DNA Chemically Liu, Xianyu
2018
9 p. 1151-1156.e3
artikel
85 Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues Hwang, Dobeen
2019
9 p. 1229-1239.e9
artikel
86 Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy Hengel, Sarah R.
2017
9 p. 1101-1119
19 p.
artikel
87 Small-molecule MHC-II inducers promote immune detection and anti-cancer immunity via editing cancer metabolism Huang, Ling

9 p. 1076-1089.e11
artikel
88 Small-Molecule Protein-Protein Interaction Inhibitor of Oncogenic Rho Signaling Diviani, Dario
2016
9 p. 1135-1146
12 p.
artikel
89 Small-Molecule Targets in Immuno-Oncology Dhanak, Dashyant
2017
9 p. 1148-1160
13 p.
artikel
90 Small Substrate or Large? Debate Over the Mechanism of Glycation Adduct Repair by DJ-1 Jun, Yong Woong

9 p. 1117-1123
artikel
91 Spliceostatin A interaction with SF3B limits U1 snRNP availability and causes premature cleavage and polyadenylation Yoshimoto, Rei

9 p. 1356-1365.e4
artikel
92 Stabilizing Protein Motifs with a Genetically Encoded Metal-Ion Chelator Luo, Xiaozhou
2016
9 p. 1098-1102
5 p.
artikel
93 Starving the Devourer: Cutting Cancer Off from Its Favorite Foods Katt, William P.
2019
9 p. 1197-1199
artikel
94 Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles Aleem, Saadat U.
2016
9 p. 1103-1112
10 p.
artikel
95 Structural and Biochemical Studies of Non-native Agonists of the LasR Quorum-Sensing Receptor Reveal an L3 Loop “Out” Conformation for LasR O'Reilly, Matthew C.
2018
9 p. 1128-1139.e3
artikel
96 Structural Insights into Mitochondrial Calcium Uniporter Regulation by Divalent Cations Lee, Samuel K.
2016
9 p. 1157-1169
13 p.
artikel
97 Substrate-Assisted Catalysis in Polyketide Reduction Proceeds via a Phenolate Intermediate Schäfer, Martin
2016
9 p. 1091-1097
7 p.
artikel
98 Synthetic Biology-Based Point-of-Care Diagnostics for Infectious Disease Wei, Ting-Yen
2016
9 p. 1056-1066
11 p.
artikel
99 Systematic Chemogenetic Library Assembly Canham, Stephen M.

9 p. 1124-1129
artikel
100 Targeted Protein Degradation: from Chemical Biology to Drug Discovery Cromm, Philipp M.
2017
9 p. 1181-1190
10 p.
artikel
101 Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System Röth, Sascha

9 p. 1151-1163.e6
artikel
102 Targeting Metabolism for Cancer Therapy Luengo, Alba
2017
9 p. 1161-1180
20 p.
artikel
103 Targeting Nucleoporin POM121-Importin β Axis in Prostate Cancer Lim, Kee Siang
2018
9 p. 1056-1058
artikel
104 The Emerging Role of RNA as a Therapeutic Target for Small Molecules Connelly, Colleen M.
2016
9 p. 1077-1090
14 p.
artikel
105 The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway De Cesare, Virginia
2018
9 p. 1117-1127.e4
artikel
106 The Meisenheimer Complex as a Paradigm in Drug Discovery: Reversible Covalent Inhibition through C67 of the ATP Binding Site of PLK1 Pearson, Russell J.
2018
9 p. 1107-1116.e4
artikel
107 The Pursuit of Therapeutic Biomarkers with High-Throughput Cancer Cell Drug Screens Williams, Steven P.
2017
9 p. 1066-1074
9 p.
artikel
108 Tumor microenvironmental nutrients, cellular responses, and cancer Lobel, Graham P.

9 p. 1015-1032
artikel
109 Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery Weeber, Fleur
2017
9 p. 1092-1100
9 p.
artikel
110 Un-FASN-ing cancer’s seat belt: Linking lipid metabolism and antigen presentation Corey, Zachary

9 p. 1004-1006
artikel
111 Vaccinology Gets Help from Chemistry Adamo, Roberto
2016
9 p. 1047-1048
2 p.
artikel
112 Winding Down: Selectively Drugging a Promiscuous Pocket in Cryptochrome Slows Circadian Rhythms Crane, Brian R.

9 p. 1109-1111
artikel
                             112 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland